Indian pharmaceutical units face a severe crisis. Input costs have surged by 200-300 percent. This is due to global conflicts disrupting ra...

Sudeep Pharma secured strong anchor investor participation ahead of its IPO, attracting major mutual funds, insurers and marquee investors,...

India's drug regulator has directed state authorities to enforce strict testing of all raw materials used in medicines. This action follows...

Ahmedabad-based Patel Chem Specialities launched its Rs 58.80 crore IPO today, priced at Rs 82–84 per share. The IPO, entirely a fresh issu...

Patel Chem Specialities' ₹58.8 crore IPO opens on July 25 and closes on July 29. Proceeds will fund a new plant, corporate needs, and expan...

The government is considering mandating bar codes or QR codes on labels for vaccines, antimicrobials, narcotics, psychotropic substances, a...

The DCGI's move comes a few days after ET reported that industrial excipients are used in manufacturing medicines and over 50 companies man...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has discovered the widespread use of industrial-grade exci...

If the proposal is approved all marketing holders will need to identify the excipients included in any human medicine authorised in the cou...

The $7 billion (CY2021) company by revenues entered India a decade ago, but after couple of years of prospecting it decided last year to ac...

They said information related to the excipients, such as drug licence, batch number and adherence to the standards laid down by the Indian ...

The state regulator has ordered a complete examination of the manufacturing processes and the excipients or solvents that are used in cough...

Marwadi Shares and Finance said that considering the FY-21 adjusted EPS of Rs.10.80 on the post-issue basis, the company is going to list a...

Marwadi Shares and Finance said considering the FY-21 adjusted EPS of Rs 10.80 on a post-issue basis, the company is going to list at a P/E...

Despite not being the talk of the town, analysts covering the issue are bullish on the company, giving it a thumbs up.

The contract with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the producti...

The drug controller has sought price details of 65 excipients used to make medicines, possibly to revise their prices that was last done in...